Monoclonal antibody 14G2a

Drug Profile

Monoclonal antibody 14G2a

Alternative Names: Murine anti-GD2 monoclonal antibody

Latest Information Update: 27 Aug 2001

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action Complement activation stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Malignant melanoma; Neuroblastoma

Most Recent Events

  • 27 Aug 2001 Discontinued-I for Neuroblastoma in USA (IV-infusion)
  • 27 Aug 2001 Discontinued-Unspecified Phase in Neuroblastoma in Germany (Infusion)
  • 27 Aug 2001 Discontinued-I for Malignant melanoma in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top